Welcome to Litha Pharma, a division of Litha Healthcare Group Limited.

Litha Healthcare Group Limited is a diversified healthcare company with headquarters in Johannesburg, South Africa.

The Litha Pharma division contributes significantly to the Group’s revenue and has become a key strategic area of growth for Litha. All its various business entities, (Pharmaplan, Litha Pharma, Pharma Africa, Goldex Healthcare and OTC Pharma SA) have numerous licence agreements, co-marketing and joint ventures with some well-known international healthcare companies. Access and ownership to product pipelines are an intrinsic part of its long-term strategy and there are many exciting new products in various stages of registration at the Medicines Control Council (MCC).

Litha Pharma’s immediate business focus is to develop greater market presence in all its distribution channels,  as well as to expand access to prescribing healthcare professionals in both the public and private sector.

Litha Pharma is present in many therapeutic areas with Complementary, OTC and scripted brands. Below are the areas we are present in.

  • Oncology
  • Gastroenterology
  • Neurology
  • Urology
  • Dermatology
  • Psychiatry
  • Nephrology
  • Cardiology
  • Gynaecology
  • Allergology
  • ENT
  • Pain Management
  • Anaesthesiology
  • Ophthalmology

should you like any further information please email:Helen.Pemberton@lithahealthcare.co.za

Litha Pharma has a resource compliment of over 120 experienced sales and marketing people which have a strong relationship with the private hospital sector in all major regions of South Africa.

Litha Pharma division currently comprises the following business entities:HPASA

  • Pharmaplan
  • Pharmafrica Goldex Healthcare
  • OTC Pharma SA

All of which are in the process of being merged and will ultimately trade as one
Litha Pharma (Pty) Ltd Brand.